MedTrace Logo

Preventing Anxiety and Depression in Older Hispanics

NCT03870360 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2026-05-15

No results posted yet for this study

Summary

The purpose of this study is to look at the best ways to prevent anxiety and depression in older Latino adults who are at risk for developing anxiety and depression. Participants will be randomized to either a health promotion intervention or a healthy lifestyles education program.

Conditions

Interventions

BEHAVIORAL

HOLA Component 1

At week 1 and week 8 participants will meet individually with Community Health Worker (CHW) for 30 minutes for a manualized social and physical activation session.

BEHAVIORAL

HOLA Component 2

A CHW led 45 minute (10 minutes of stretching and warm up, followed by 30 minutes of walking with a 5 minute cool down) group walk session of six participants at a time done 3 times a week that utilized interval training that slowly gradually increases in intensity.

BEHAVIORAL

HOLA Component 3

A CHW led pleasant event discussion, asking each participant to identify a pleasant event. This task is done in conjunction with the cool down of HOLA 2.

BEHAVIORAL

HOLA Component 4

One booster walking session twice a month for six months post intervention for reinforcement, then one booster walking session a month for eighteen months.

BEHAVIORAL

Healthy lifestyles education program

Biweekly telephone check in calls for the first 16 weeks followed by monthly check in calls during the two year follow up period.

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • University of Miami

    lead OTHER

Principal Investigators

  • Daniel E. Jimenez, Ph.D. · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2026-11-01
Completion
2026-11-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03870360 on ClinicalTrials.gov